Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating a canine and inhibiting NGF activity through use of anti-NGF antibodies

Methods of treating a canine and inhibiting NGF activity through use of anti-NGF antibodies

US Patent 12084506 · Granted Sep 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids encoding canine anti-NGF antibodies and methods thereof2025
Nucleic acids encoding canine anti-NGF antibodies and methods thereof2025
Nucleic acids encoding canine anti-NGF antibodies and methods thereof2025
Nucleic acids encoding canine anti-NGF antibodies and methods thereof2025
Method of determining the identity and/or amount of an anti-IL-31 antibody in a 2025
Anti-coronavirus vaccines2025
Interleukin-31 monoclonal antibodies for veterinary use2024
Interleukin-31 monoclonal antibodies for veterinary use2024
Humanized anti-NGF antibodies and methods of treating pain thereof2024
Humanized anti-NGF antibodies and methods of treating pain thereof2024
Humanized anti-NGF antibodies and methods of treating pain thereof2024
Humanized anti-NGF antibodies and methods of treating pain thereof2024